Abstract 6390: Nanoprimer technology for enhanced efficacy of intravenously administered vaccines.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Matthieu Germain, Maxime Bergere, Francis Mpambani, Jordan Da Silva, Andromeda Savary, Sebastien Paris, Laurence Poul, Julie Devalliere
Institution: Nanobiotix (France)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148671378
Cites:
Cited by:
Related to: